CA1335592C - Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds - Google Patents

Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds

Info

Publication number
CA1335592C
CA1335592C CA000593185A CA593185A CA1335592C CA 1335592 C CA1335592 C CA 1335592C CA 000593185 A CA000593185 A CA 000593185A CA 593185 A CA593185 A CA 593185A CA 1335592 C CA1335592 C CA 1335592C
Authority
CA
Canada
Prior art keywords
compound
formula
carboxamide
thiazolyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000593185A
Other languages
English (en)
French (fr)
Inventor
Banavara Lakshmana Mylari
Joseph George Lombardino
James Michael Mcmanus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of CA1335592C publication Critical patent/CA1335592C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA000593185A 1988-03-11 1989-03-09 Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds Expired - Fee Related CA1335592C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US88/00781 1988-03-11
PCT/US1988/000781 WO1989008654A1 (en) 1988-03-11 1988-03-11 Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds

Publications (1)

Publication Number Publication Date
CA1335592C true CA1335592C (en) 1995-05-16

Family

ID=22208596

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000593185A Expired - Fee Related CA1335592C (en) 1988-03-11 1989-03-09 Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds

Country Status (15)

Country Link
EP (1) EP0332364A3 (no)
JP (1) JPH0676408B2 (no)
KR (1) KR910002565B1 (no)
AU (1) AU605410B2 (no)
CA (1) CA1335592C (no)
DK (1) DK169723B1 (no)
FI (1) FI96315C (no)
HU (1) HU201757B (no)
IL (1) IL89480A (no)
MY (1) MY104955A (no)
NO (1) NO170418C (no)
NZ (1) NZ228299A (no)
PT (1) PT89954B (no)
WO (1) WO1989008654A1 (no)
ZA (1) ZA891800B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
JPH06279444A (ja) * 1993-03-31 1994-10-04 Tokyo Tanabe Co Ltd インドリジン誘導体
JP2002504549A (ja) * 1998-02-26 2002-02-12 ニューロゲン コーポレイション ベンジルピペラジニル−およびベンジルピペリジニルエタノン誘導体、その調製、およびドーパミンｄ４受容体アンタゴニストとしてのその使用
US6084098A (en) 1999-02-26 2000-07-04 Neurogen Corporation Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
CN101014345A (zh) * 2004-09-09 2007-08-08 默克公司 三环酰苯胺螺环内酰胺cgrp受体拮抗剂
AU2005285083B2 (en) * 2004-09-13 2011-03-10 Merck Sharp & Dohme Corp. Tricyclic anilide spirohydantoin CGRP receptor antagonists
US7741317B2 (en) * 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
CN108853102B (zh) * 2017-05-15 2021-04-09 北京大学 作用于Dectin-1的稠合吖啶衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1394373A (en) * 1972-05-17 1975-05-14 Pfizer Ltd Control of plant diseases
EP0139584B1 (fr) * 1983-10-17 1988-05-18 Synthelabo Dérivés d'imidazoline, leur préparation et leur application en thérapeutique
FR2567126B1 (fr) * 1984-07-06 1986-12-12 Synthelabo Derives de pyrrolo(1,2,3-de) benzoxazine et benzothiazine, leur preparation et leur application en therapeutique
JPS6317885A (ja) * 1986-07-11 1988-01-25 Kyorin Pharmaceut Co Ltd スピロピロリジン−２，５−ジオン誘導体の製造方法

Also Published As

Publication number Publication date
JPH01275580A (ja) 1989-11-06
NO894350L (no) 1989-11-01
HU201757B (en) 1990-12-28
AU3120489A (en) 1989-09-14
EP0332364A3 (en) 1991-04-03
WO1989008654A1 (en) 1989-09-21
MY104955A (en) 1994-07-30
PT89954B (pt) 1994-05-31
KR890014545A (ko) 1989-10-24
AU605410B2 (en) 1991-01-10
NZ228299A (en) 1990-09-26
FI895333A0 (fi) 1989-11-09
IL89480A (en) 1994-04-12
FI96315B (fi) 1996-02-29
PT89954A (pt) 1989-11-10
DK116689A (da) 1989-09-12
NO170418B (no) 1992-07-06
FI96315C (fi) 1996-06-10
EP0332364A2 (en) 1989-09-13
JPH0676408B2 (ja) 1994-09-28
ZA891800B (en) 1990-10-31
NO170418C (no) 1992-10-14
NO894350D0 (no) 1989-11-01
DK169723B1 (da) 1995-01-23
DK116689D0 (da) 1989-03-10
IL89480A0 (en) 1989-09-10
KR910002565B1 (ko) 1991-04-26
HU885829D0 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
CA1289137C (en) Imidazoquinolinylether derivatives
AU592983B2 (en) Imidazoquinoline antithrombogenic cardiotonicagents
US5624931A (en) Pyrazole derivatives
EP0547708B1 (en) Saccharin derivative proteolytic enzyme inhibitors
US5646141A (en) Compounds useful as antiproliferative agents and GARFT inhibitors
US5416211A (en) Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
CA1309095C (en) Aminoimidazoquinoline derivatives
WO1992012154A1 (en) Imidazotriazine derivatives
CA1335592C (en) Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
CA1248532A (en) Pyrazolo¬3,4-b|pyridine derivatives and process for producing them
US5644058A (en) Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
US5438052A (en) Cephalosporin derivatives
KR870001144B1 (ko) 삼환 옥스인돌 카복스아미드 유도체의 제조방법
NZ225754A (en) Cephalosporin derivatives; medicaments and methods for preparation and treatment
CA2241690A1 (en) Pyrido(2,3-b)pyrazine derivatives
US5624929A (en) Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
Cecchetti et al. 1, 4‐Benzothiazine‐2‐carboxylic acid 1‐oxides as analogues of antibacterial quinolones
EP0294994B1 (en) 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides
US5403839A (en) Pyrrolophenothiazine carboxamides
EP0306300B1 (en) Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
CA2631794A1 (en) P38 kinase inhibiting agents
JPH0441151B2 (no)
GB2024207A (en) New tricyclic ortho-fused heterocyclic compounds
CA2000258A1 (en) Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors

Legal Events

Date Code Title Description
MKLA Lapsed